-
IBB Dashboard
- Holdings
iShares Biotechnology ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
BlackRock Cash Funds: Institutional, SL Agency Shares | 892.45 mm | 891.74 mm shares | 11.80 | Short-term investment vehicle | Long | USA |
GILD Gilead Sciences, Inc. | 651.88 mm | 7.78 mm shares | 8.62 | Common equity | Long | USA |
AMGN Amgen Inc. | 592.87 mm | 1.84 mm shares | 7.84 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 576.08 mm | 1.24 mm shares | 7.62 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 545.06 mm | 518.49 k shares | 7.21 | Common equity | Long | USA |
IQV IQVIA Holdings Inc. | 312.57 mm | 1.32 mm shares | 4.13 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 255.27 mm | 928.16 k shares | 3.38 | Common equity | Long | USA |
MTD Mettler-Toledo International Inc. | 230.07 mm | 153.41 k shares | 3.04 | Common equity | Long | USA |
BIIB Biogen Inc. | 204.40 mm | 1.05 mm shares | 2.70 | Common equity | Long | USA |
ARGX argenx SE | 200.86 mm | 370.54 k shares | 2.66 | Common equity | Long | Netherlands |
BNTX BioNTech SE | 175.51 mm | 1.48 mm shares | 2.32 | Common equity | Long | Germany |
MRNA Moderna, Inc. | 167.06 mm | 2.50 mm shares | 2.21 | Common equity | Long | USA |
WAT Waters Corporation | 155.48 mm | 432.02 k shares | 2.06 | Common equity | Long | USA |
ILMN Illumina, Inc. | 150.79 mm | 1.16 mm shares | 1.99 | Common equity | Long | USA |
ONC BeiGene, Ltd. | 134.50 mm | 599.10 k shares | 1.78 | Common equity | Long | Cayman Islands |
UTHR United Therapeutics Corporation | 114.28 mm | 318.91 k shares | 1.51 | Common equity | Long | USA |
NTRA Natera, Inc. | 107.59 mm | 847.49 k shares | 1.42 | Common equity | Long | USA |
Genmab A/S
|
100.51 mm | 4.12 mm shares | 1.33 | Common equity | Long | Denmark |
BMRN BioMarin Pharmaceutical Inc. | 96.40 mm | 1.37 mm shares | 1.27 | Common equity | Long | USA |
INCY Incyte Corporation | 91.78 mm | 1.39 mm shares | 1.21 | Common equity | Long | USA |
TECH Bio-Techne Corporation | 91.50 mm | 1.14 mm shares | 1.21 | Common equity | Long | USA |
INSM Insmed Incorporated | 89.20 mm | 1.22 mm shares | 1.18 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 89.09 mm | 779.62 k shares | 1.18 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 82.99 mm | 720.28 k shares | 1.10 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 81.51 mm | 652.68 k shares | 1.08 | Common equity | Long | USA |
CRL Charles River Laboratories International, Inc. | 73.35 mm | 372.37 k shares | 0.97 | Common equity | Long | USA |
MEDP Medpace Holdings, Inc. | 62.05 mm | 185.90 k shares | 0.82 | Common equity | Long | USA |
RGEN Repligen Corporation | 56.54 mm | 379.93 k shares | 0.75 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 54.71 mm | 1.12 mm shares | 0.72 | Common equity | Long | Cayman Islands |
ASND Ascendis Pharma A/S | 52.99 mm | 354.90 k shares | 0.70 | Common equity | Long | Denmark |
ITCI Intra-Cellular Therapies, Inc. | 52.72 mm | 720.52 k shares | 0.70 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 52.64 mm | 2.03 mm shares | 0.70 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 52.33 mm | 914.19 k shares | 0.69 | Common equity | Long | USA |
BRKR Bruker Corporation | 51.91 mm | 751.67 k shares | 0.69 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 45.92 mm | 1.01 mm shares | 0.61 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 43.81 mm | 829.73 k shares | 0.58 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 41.96 mm | 453.67 k shares | 0.55 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 39.15 mm | 977.40 k shares | 0.52 | Common equity | Long | USA |
Roivant Sciences Ltd.
|
37.30 mm | 3.23 mm shares | 0.49 | Common equity | Long | Bermuda |
RNA Avidity Biosciences, Inc. | 36.42 mm | 792.95 k shares | 0.48 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 34.90 mm | 628.27 k shares | 0.46 | Common equity | Long | USA |
Alkermes plc
|
32.96 mm | 1.18 mm shares | 0.44 | Common equity | Long | Ireland |
ADMA ADMA Biologics, Inc. | 32.81 mm | 1.64 mm shares | 0.43 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 32.05 mm | 176.06 k shares | 0.42 | Common equity | Long | USA |
Biohaven Ltd.
|
29.68 mm | 593.98 k shares | 0.39 | Common equity | Long | Virgin Islands (British) |
CRNX Crinetics Pharmaceuticals, Inc. | 27.98 mm | 547.53 k shares | 0.37 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
27.96 mm | 595.12 k shares | 0.37 | Common equity | Long | Switzerland |
Madrigal Pharmaceuticals, Inc. | 27.91 mm | 131.50 k shares | 0.37 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 26.12 mm | 1.03 mm shares | 0.35 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 25.65 mm | 285.41 k shares | 0.34 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 25.25 mm | 866.76 k shares | 0.33 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 24.98 mm | 244.14 k shares | 0.33 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 24.51 mm | 293.51 k shares | 0.32 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 22.48 mm | 2.10 mm shares | 0.30 | Common equity | Long | USA |
Merus NV
|
21.58 mm | 431.88 k shares | 0.29 | Common equity | Long | Netherlands |
XENE Xenon Pharmaceuticals Inc. | 21.23 mm | 539.26 k shares | 0.28 | Common equity | Long | Canada |
APLS Apellis Pharmaceuticals, Inc. | 21.20 mm | 735.16 k shares | 0.28 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 20.87 mm | 398.45 k shares | 0.28 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 20.16 mm | 543.45 k shares | 0.27 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 19.77 mm | 417.64 k shares | 0.26 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 19.51 mm | 543.04 k shares | 0.26 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 18.81 mm | 552.71 k shares | 0.25 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 18.51 mm | 409.60 k shares | 0.24 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 18.50 mm | 1.20 mm shares | 0.24 | Common equity | Long | USA |
GERN Geron Corporation | 18.30 mm | 4.03 mm shares | 0.24 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 18.29 mm | 406.46 k shares | 0.24 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 17.90 mm | 402.93 k shares | 0.24 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 17.71 mm | 559.05 k shares | 0.23 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 17.44 mm | 636.88 k shares | 0.23 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 16.77 mm | 865.66 k shares | 0.22 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 16.63 mm | 1.77 mm shares | 0.22 | Common equity | Long | USA |
TXG 10x Genomics, Inc. | 16.42 mm | 727.36 k shares | 0.22 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 15.93 mm | 271.19 k shares | 0.21 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 15.66 mm | 488.65 k shares | 0.21 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 15.00 mm | 341.81 k shares | 0.20 | Common equity | Long | Cayman Islands |
VCEL Vericel Corporation | 15.00 mm | 355.01 k shares | 0.20 | Common equity | Long | USA |
BlackRock Cash Funds: Treasury, SL Agency Shares | 14.98 mm | 14.98 mm shares | 0.20 | Short-term investment vehicle | Long | USA |
NTLA Intellia Therapeutics, Inc. | 14.97 mm | 728.29 k shares | 0.20 | Common equity | Long | USA |
Zai Lab Ltd.
|
14.92 mm | 617.88 k shares | 0.20 | Common equity | Long | Cayman Islands |
GRFS Grifols, S.A. | 14.45 mm | 1.63 mm shares | 0.19 | Common equity | Long | Spain |
NVAX Novavax, Inc. | 14.03 mm | 1.11 mm shares | 0.19 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 13.74 mm | 627.53 k shares | 0.18 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 13.35 mm | 302.04 k shares | 0.18 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals Incorporated | 13.04 mm | 130.28 k shares | 0.17 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 12.89 mm | 452.24 k shares | 0.17 | Common equity | Long | USA |
FTRE Fortrea Holdings Inc. | 12.85 mm | 642.48 k shares | 0.17 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 12.81 mm | 522.95 k shares | 0.17 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 12.56 mm | 276.57 k shares | 0.17 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 12.53 mm | 215.78 k shares | 0.17 | Common equity | Long | USA |
MNKD MannKind Corporation | 12.23 mm | 1.94 mm shares | 0.16 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 12.16 mm | 424.00 k shares | 0.16 | Common equity | Long | USA |
Galapagos NV
|
11.58 mm | 402.38 k shares | 0.15 | Common equity | Long | Belgium |
EWTX Edgewise Therapeutics, Inc. | 11.37 mm | 426.06 k shares | 0.15 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 11.31 mm | 612.25 k shares | 0.15 | Common equity | Long | USA |
VRNA Verona Pharma plc | 11.29 mm | 392.31 k shares | 0.15 | Common equity | Long | UK |
CDNA CareDx, Inc | 11.28 mm | 361.11 k shares | 0.15 | Common equity | Long | USA |
Novocure Ltd.
|
11.13 mm | 712.37 k shares | 0.15 | Common equity | Long | Jersey |
SNDX Syndax Pharmaceuticals, Inc. | 11.13 mm | 578.30 k shares | 0.15 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 10.81 mm | 1.42 mm shares | 0.14 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 10.78 mm | 276.45 k shares | 0.14 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 10.69 mm | 433.98 k shares | 0.14 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 10.61 mm | 952.70 k shares | 0.14 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 10.40 mm | 462.71 k shares | 0.14 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 10.37 mm | 1.57 mm shares | 0.14 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 9.44 mm | 303.30 k shares | 0.12 | Common equity | Long | UK |
KURA Kura Oncology, Inc. | 9.26 mm | 473.83 k shares | 0.12 | Common equity | Long | USA |
XNCR Xencor, Inc. | 8.84 mm | 439.50 k shares | 0.12 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 7.74 mm | 553.36 k shares | 0.10 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals, Inc. | 7.63 mm | 231.95 k shares | 0.10 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 7.53 mm | 471.18 k shares | 0.10 | Common equity | Long | UK |
Stevanato Group SpA
|
7.25 mm | 362.69 k shares | 0.10 | Common equity | Long | Italy |
Kiniksa Pharmaceuticals International plc
|
7.08 mm | 283.27 k shares | 0.09 | Common equity | Long | UK |
MRVI Maravai LifeSciences Holdings, Inc. | 7.04 mm | 847.04 k shares | 0.09 | Common equity | Long | USA |
AUPH Aurinia Pharmaceuticals Inc. | 6.89 mm | 940.08 k shares | 0.09 | Common equity | Long | Canada |
ARQT Arcutis Biotherapeutics, Inc. | 6.88 mm | 739.60 k shares | 0.09 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 6.52 mm | 603.96 k shares | 0.09 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 6.39 mm | 282.30 k shares | 0.08 | Common equity | Long | UK |
Zymeworks Inc. | 6.39 mm | 508.93 k shares | 0.08 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 6.21 mm | 185.36 k shares | 0.08 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 6.02 mm | 432.24 k shares | 0.08 | Common equity | Long | USA |
WaVe Life Sciences Ltd.
|
5.89 mm | 717.96 k shares | 0.08 | Common equity | Long | Singapore |
Prothena Corp. plc
|
5.67 mm | 339.15 k shares | 0.08 | Common equity | Long | Ireland |
IRON Disc Medicine, Inc. | 5.56 mm | 113.18 k shares | 0.07 | Common equity | Long | USA |
OLK Olink Holding AB (publ) | 5.45 mm | 209.80 k shares | 0.07 | Common equity | Long | Sweden |
RCUS Arcus Biosciences, Inc. | 5.42 mm | 354.30 k shares | 0.07 | Common equity | Long | USA |
CSTL Castle Biosciences, Inc. | 5.40 mm | 189.40 k shares | 0.07 | Common equity | Long | USA |
ELVN Enliven Therapeutics, Inc. | 5.37 mm | 210.32 k shares | 0.07 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 5.36 mm | 1.48 mm shares | 0.07 | Common equity | Long | UK |
ADPT Adaptive Biotechnologies Corporation | 5.34 mm | 1.04 mm shares | 0.07 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 5.34 mm | 721.17 k shares | 0.07 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 5.15 mm | 355.30 k shares | 0.07 | Common equity | Long | USA |
CTKB Cytek Biosciences, Inc. | 4.82 mm | 869.61 k shares | 0.06 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 4.78 mm | 637.72 k shares | 0.06 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 4.74 mm | 670.08 k shares | 0.06 | Common equity | Long | USA |
CGEM Cullinan Oncology, Inc. | 4.72 mm | 281.79 k shares | 0.06 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals, Inc. | 4.68 mm | 1.14 mm shares | 0.06 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 4.37 mm | 389.44 k shares | 0.06 | Common equity | Long | USA |
PHAT Phathom Pharmaceuticals, Inc. | 4.29 mm | 237.12 k shares | 0.06 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals, Inc. | 4.28 mm | 358.31 k shares | 0.06 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 4.21 mm | 384.05 k shares | 0.06 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 4.19 mm | 180.41 k shares | 0.06 | Common equity | Long | USA |
ABUS Arbutus Biopharma Corporation | 4.12 mm | 1.07 mm shares | 0.05 | Common equity | Long | Canada |
ABCL AbCellera Biologics Inc. | 3.92 mm | 1.51 mm shares | 0.05 | Common equity | Long | Canada |
SRRK Scholar Rock Holding Corporation | 3.82 mm | 477.28 k shares | 0.05 | Common equity | Long | USA |
HUMA Humacyte, Inc. | 3.69 mm | 677.51 k shares | 0.05 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 3.68 mm | 884.29 k shares | 0.05 | Common equity | Long | USA |
OPK OPKO Health, Inc. | 3.57 mm | 2.40 mm shares | 0.05 | Common equity | Long | USA |
RVNC Revance Therapeutics, Inc. | 3.55 mm | 684.95 k shares | 0.05 | Common equity | Long | USA |
UroGen Pharma Ltd.
|
3.54 mm | 278.47 k shares | 0.05 | Common equity | Long | Israel |
YMAB Y-mAbs Therapeutics, Inc. | 3.54 mm | 268.88 k shares | 0.05 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 3.45 mm | 319.20 k shares | 0.05 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corp. | 3.42 mm | 602.25 k shares | 0.05 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 3.39 mm | 323.08 k shares | 0.04 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 3.38 mm | 330.03 k shares | 0.04 | Common equity | Long | USA |
ERAS Erasca, Inc. | 3.31 mm | 1.21 mm shares | 0.04 | Common equity | Long | USA |
QTRX Quanterix Corporation | 3.31 mm | 255.29 k shares | 0.04 | Common equity | Long | USA |
EXAI Exscientia plc | 3.27 mm | 669.24 k shares | 0.04 | Common equity | Long | UK |
TNGX Tango Therapeutics, Inc. | 3.22 mm | 418.25 k shares | 0.04 | Common equity | Long | USA |
NxStage Medical, Inc. | 3.22 mm | 1.89 mm shares | 0.04 | Common equity | Long | USA |
FLGT Fulgent Genetics, Inc. | 3.12 mm | 143.72 k shares | 0.04 | Common equity | Long | USA |
TERN Terns Pharmaceuticals, Inc. | 2.92 mm | 350.35 k shares | 0.04 | Common equity | Long | USA |
SVRA Savara Inc. | 2.84 mm | 669.16 k shares | 0.04 | Common equity | Long | USA |
TRML Tourmaline Bio, Inc. | 2.80 mm | 109.02 k shares | 0.04 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 2.79 mm | 996.90 k shares | 0.04 | Common equity | Long | USA |
NUVB Nuvation Bio Inc. | 2.75 mm | 1.20 mm shares | 0.04 | Common equity | Long | USA |
MXCT MaxCyte, Inc. | 2.75 mm | 707.37 k shares | 0.04 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 2.65 mm | 367.32 k shares | 0.04 | Common equity | Long | USA |
Theravance Biopharma, Inc.
|
2.65 mm | 328.80 k shares | 0.04 | Common equity | Long | Cayman Islands |
ALEC Alector, Inc. | 2.60 mm | 558.16 k shares | 0.03 | Common equity | Long | USA |
KALV KalVista Pharmaceuticals, Inc. | 2.52 mm | 217.32 k shares | 0.03 | Common equity | Long | USA |
CMPS COMPASS Pathways plc | 2.42 mm | 384.67 k shares | 0.03 | Common equity | Long | UK |
TSHA Taysha Gene Therapies, Inc. | 2.32 mm | 1.15 mm shares | 0.03 | Common equity | Long | USA |
SLRN Acelyrin, Inc. | 2.31 mm | 468.90 k shares | 0.03 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 2.20 mm | 455.13 k shares | 0.03 | Common equity | Long | USA |
DNA Ginkgo Bioworks Holdings, Inc. | 2.12 mm | 260.20 k shares | 0.03 | Common equity | Long | USA |
ITOS iTeos Therapeutics, Inc. | 2.09 mm | 205.12 k shares | 0.03 | Common equity | Long | USA |
BMEA Biomea Fusion, Inc. | 2.09 mm | 206.62 k shares | 0.03 | Common equity | Long | USA |
EDIT Editas Medicine, Inc. | 2.00 mm | 587.46 k shares | 0.03 | Common equity | Long | USA |
Immutep Limited | 2.00 mm | 906.40 k shares | 0.03 | Common equity | Long | Australia |
MLYS Mineralys Therapeutics, Inc. | 1.98 mm | 163.85 k shares | 0.03 | Common equity | Long | USA |
CureVac NV
|
1.98 mm | 674.14 k shares | 0.03 | Common equity | Long | Netherlands |
VYGR Voyager Therapeutics, Inc. | 1.94 mm | 331.57 k shares | 0.03 | Common equity | Long | USA |
VNDA Vanda Pharmaceuticals Inc. | 1.88 mm | 400.13 k shares | 0.02 | Common equity | Long | USA |
AVIR Atea Pharmaceuticals, Inc. | 1.78 mm | 530.60 k shares | 0.02 | Common equity | Long | USA |
AC Immune SA
|
1.70 mm | 449.85 k shares | 0.02 | Common equity | Long | Switzerland |
ZNTL Zentalis Pharmaceuticals, Inc. | 1.64 mm | 446.64 k shares | 0.02 | Common equity | Long | USA |
uniQure NV
|
1.61 mm | 326.55 k shares | 0.02 | Common equity | Long | Netherlands |
MeiraGTx Holdings plc
|
1.58 mm | 379.62 k shares | 0.02 | Common equity | Long | Cayman Islands |
NAUT Nautilus Biotechnology, Inc. | 1.53 mm | 538.07 k shares | 0.02 | Common equity | Long | USA |
FULC Fulcrum Therapeutics, Inc. | 1.50 mm | 421.38 k shares | 0.02 | Common equity | Long | USA |
THRD Third Harmonic Bio, Inc. | 1.49 mm | 109.73 k shares | 0.02 | Common equity | Long | USA |
CABA Cabaletta Bio, Inc. | 1.44 mm | 305.71 k shares | 0.02 | Common equity | Long | USA |
PRME Prime Medicine, Inc. | 1.40 mm | 362.71 k shares | 0.02 | Common equity | Long | USA |
MGNX MacroGenics, Inc. | 1.34 mm | 408.19 k shares | 0.02 | Common equity | Long | USA |
NBTX Nanobiotix S.A. | 1.31 mm | 228.48 k shares | 0.02 | Common equity | Long | France |
CRBU Caribou Biosciences, Inc. | 1.16 mm | 592.59 k shares | 0.02 | Common equity | Long | USA |
LYEL Lyell Immunopharma, Inc. | 1.14 mm | 823.11 k shares | 0.02 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals, Inc. | 979.36 k | 302.27 k shares | 0.01 | Common equity | Long | USA |
ATAI Life Sciences NV
|
954.08 k | 822.48 k shares | 0.01 | Common equity | Long | Netherlands |
VTYX Ventyx Biosciences, Inc. | 848.94 k | 389.42 k shares | 0.01 | Common equity | Long | USA |